14 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PRONEB ULTRA MODEL NUMBER 85B0100

FDA 510(k)
FDA Class 2 ·Anesthesiology

Merit Medical®

FDA UDI
Merit Medical Systems, Inc.·00884450269060·

SYNTHETIC POWDER FREE (WHITE) VINYL PATIENT EXAMINATION GLOVES

FDA 510(k)
FDA Class 1 ·General Hospital

SAMSUNG 10DR IMPLANT SYSTEM

FDA 510(k)
FDA Class 2 ·Dental

INSET

FDA Adverse Event
Malfunction ·UNOMEDICAL UM-D·Product code FPA·March 31, 2026

KIT,LAP CHOLE (CGWG )186

FDA Adverse Event
Injury ·CARDINAL HEALTH·Product code LRO·March 27, 2013

EV1000 CLINICAL PLATFORM

FDA Adverse Event
Malfunction ·EDWARDS LIFESCIENCES·Product code DXG·March 13, 2013

ASR ACETABULAR CUPS 52

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL, LTD·Product code KWA·February 16, 2011

IMPLANTIUM

FDA Adverse Event
Other ·DENTIUM CO., LTD.·Product code DZE·February 22, 2008

NCOMPASS NITINOL TIPLESS STONE EXTRACTOR

FDA Adverse Event
Malfunction ·COOK INC·Product code FFL·March 28, 2018

NCOMPASS NITINOL TIPLESS STONE EXTRACTOR

FDA Adverse Event
Malfunction ·COOK INC·Product code FFL·May 9, 2018

Ultrasound System 1300, bkSpecto w/battery; Model No. 1300-21 or 1300-S1; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024